Ritu Ojha
Affiliations: | 2018 | College of Pharmacy | Taipei Medical University |
Google:
"Ritu Ojha"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ojha R, Chen IC, Hsieh CM, et al. (2021) Installation of Pargyline, a LSD1 Inhibitor, in the HDAC Inhibitory Template Culminated in the Identification of a Tractable Antiprostate Cancer Agent. Journal of Medicinal Chemistry |
| Ojha R, Nepali K, Chen CH, et al. (2020) Corrigendum to"Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo"[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086]. European Journal of Medicinal Chemistry. 201: 112404 |
| Ojha R, Nepali K, Chen CH, et al. (2020) Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo. European Journal of Medicinal Chemistry. 190: 112086 |
| Thakur A, Singh A, Kaur N, et al. (2019) Steering the antitumor drug discovery campaign towards structurally diverse indolines. Bioorganic Chemistry. 103436 |
| Lai MJ, Ojha R, Lin MH, et al. (2018) 1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase. European Journal of Medicinal Chemistry. 162: 612-630 |
| Ojha R, Huang HL, HuangFu WC, et al. (2018) 1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC. European Journal of Medicinal Chemistry. 150: 667-677 |
| Nepali K, Lee HY, Lai MJ, et al. (2016) Ring-opened tetrahydro-γ-carbolines display cytotoxicity and selectivity with histone deacetylase isoforms. European Journal of Medicinal Chemistry. 127: 115-127 |
| Ojha R, Singh J, Ojha A, et al. (2016) An updated patent review: Xanthine oxidase inhibitors for the treatment of hyperuricemia and gout (2011-2015). Expert Opinion On Therapeutic Patents |
| Nepali K, Ojha R, Lee HY, et al. (2016) Early investigational tubulin inhibitors as novel cancer therapeutics. Expert Opinion On Investigational Drugs |
| Singh H, Sharma S, Ojha R, et al. (2014) Synthesis and evaluation of naphthoflavones as a new class of non purine xanthine oxidase inhibitors. Bioorganic & Medicinal Chemistry Letters. 24: 4192-7 |